Stock DANCAN DANCANN PHARMA A/S
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Dancann Pharma A/S

Equities

DANCAN

DK0061410487

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 23:00:00 28/04/2024 BST 		5-day change 1st Jan Change
0.06 DKK +7.14% Intraday chart for Dancann Pharma A/S +40.19% +100.00%
03-29 Dancann Pharma Plans Up to DKK19 Million Rights Issue MT
02-28 DanCann Pharma Notes Cannabis Legalization in Germany as Shares Surge MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Dancann Pharma Plans Up to DKK19 Million Rights Issue
DanCann Pharma Notes Cannabis Legalization in Germany as Shares Surge
Dancann Pharma A/S Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Dancann Pharma A/S Reports Earnings Results for the Full Year Ended December 31, 2023
Dancann Pharma A/S Provides Revenue Guidance for the Financial Year 2025
Dancann Pharma A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
DanCann Pharma Issues New Shares For Debt Conversion
DanCann Pharma Issues New Shares Upon Debt Conversion
Dancann Pharma A/S Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
DanCann Mulls Sale of Production Facility Amid Shift in Business Strategy; Shares Plunge 13%
DanCann Pharma Issues New Shares Upon Debt Conversion
Dancann Pharma Lands DKK7 Million Debt Financing From Nordic Growth Fund; Shares Up 11%
Dancann Pharma A/S' Pre-Validation Batches Meets European Standards, Paving the Path for Final Product Approval
Dancann Pharma A/S Reports Earnings Results for the First Quarter Ended March 31, 2023
Dancann Pharma A/S Appoints Louise Bertelsen Forman as A New Additional Board Member
Dancann Pharma A/S Reports Earnings Results for the Full Year Ended December 31, 2022
Dancann Pharma A/S Auditor Raises 'Going Concern' Doubt
DanCann Pharma to Distribute Prescription Cannabinoid-based Medications in Scandinavian Markets
Dancann Pharma A/S Provides Positive Insight on Progress of Cannabis Bulk Product Approval
Dancann Pharma A/S and Canngros Aps Open Office in Odense
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DANCAN Stock
  4. News Dancann Pharma A/S
  5. Other languages